Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer

Yuka Takahashi, Miwako Iwai, Taketo Kawai, Atsushi Arakawa, Takeshi Ito, Mika Sakurai-Yageta, Akihiko Ito, Akiteru Goto, Mitsue Saito, Fujio Kasumi, Yoshinori Murakami

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background The tumor suppressor genes CADM1/TSLC1 and DAL-1/4.1B are frequently inactivated by promoter methylation in non-small cell lung cancer. The proteins they encode, CADM1 and 4.1B, form a complex in human epithelial cells and are involved in cell-cell adhesion. Methods Expression of CADM1 and 4.1B proteins was examined by immunohistochemistry in 67 primary breast cancer and adjacent noncancerous tissues. CADM1 and 4.1B messenger RNA (mRNA) was detected by reversetranscription polymerase chain reaction (RT-PCR). The methylation status of the CADM1 and 4.1B promoters was determined quantitatively by bisulfite treatment followed by pyrosequencing. Results CADM1 and 4.1B protein signals were detected along the cell membrane in normal mammary epithelia. By contrast, 47 (70%) and 49 (73%) of 67 primary breast cancers showed aberrant CADM1 and 4.1B staining, respectively. Aberrant CADM1 staining was more frequently observed in pT2 and pT3 tumors and for stages II and III (P = 0.045 and P = 0.020, respectively), while aberrant 4.1B staining was more often observed in tumors with lymph node metastasis, for pT2 and pT3 tumors, and for stages II and III (P = 0.0058, P = 0.0098, and P = 0.0007, respectively). Furthermore, aberrant CADM1 and 4.1B expression was preferentially observed in invasive relative to noninvasive lesions from the same specimen (P = 0.036 and P = 0.0009, respectively). Finally, hypermethylation of CADM1 and 4.1B genes was detected in 46% and 42% of primary breast cancers, respectively. Conclusions Our findings suggest that aberrant CADM1 and 4.1B expression is involved in progression of breast cancer, especially in invasion into the stroma and metastasis.

Original languageEnglish
Pages (from-to)242-252
Number of pages11
JournalBreast Cancer
Volume19
Issue number3
DOIs
Publication statusPublished - 2012 Jul 1
Externally publishedYes

Keywords

  • 4.1B
  • Breast cancer
  • CADM1
  • Methylation
  • Tumor suppressor protein

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Takahashi, Y., Iwai, M., Kawai, T., Arakawa, A., Ito, T., Sakurai-Yageta, M., Ito, A., Goto, A., Saito, M., Kasumi, F., & Murakami, Y. (2012). Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer. Breast Cancer, 19(3), 242-252. https://doi.org/10.1007/s12282-011-0272-7